Rabaca, Mary Jane H.

HRN: 19-45-36  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2022
CEFUROXIME 500MG (TAB)
12/13/2022
12/20/2022
PO
1 Cap
BID
S/p Nsvd; Prom X 42 HRS
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: